Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes-Reference-Cited by-同舟云学术

Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes

Published:2013-11-13 Issue:6 Volume:25 Page:515-526
ISSN:1742-6731
Container-title:Emergency Medicine Australasia
language:en
Short-container-title:Emerg Med Australas

Author:

Kline Jeffrey A¹²,Hernandez Jackeline³,Hogg Melanie M³,Jones Alan E⁴,Courtney D Mark⁵,Kabrhel Christopher⁶,Nordenholz Kristen E⁷,Diercks Deborah B⁸,Rondina Matthew T⁹,Klinger James R¹⁰

Affiliation:

1. Department of Emergency Medicine; Indiana University School of Medicine; Indianapolis Indiana USA

2. Department of Cellular and Integrative Physiology; Indiana University School of Medicine; Indianapolis Indiana USA

3. Department of Emergency Medicine; Carolinas Medical Center; Charlotte North Carolina USA

4. Department of Emergency Medicine; University of Mississippi Medical Center; Jackson Mississippi USA

5. Department of Emergency Medicine; Feinberg School of Medicine; Northwestern University; Chicago Illinois USA

6. Department of Emergency Medicine; Massachusetts General Hospital; Boston Massachusetts USA

7. Department of Emergency Medicine; School of Medicine Aurora; University of Colorado; Boulder Colorado USA

8. Department of Emergency Medicine; University of California, Davis; Sacramento California USA

9. Department of Internal Medicine; University of Utah; Salt Lake City Utah USA

10. Department of Internal Medicine; Brown University School of Medicine; Providence Rhode Island USA

Publisher

Wiley

Subject

Emergency Medicine

Reference52 articles.

1. Thrombolytic therapy for pulmonary embolism;Dong;Cochrane Database Syst. Rev.,2009

2. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.[see comment;Wan;Circulation,2004

3. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the american heart association;Jaff;Circulation,2011

4. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Holbrook;Chest,2012

5. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?. [Review] [18 refs];Worster;Ann. Emerg. Med.,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombolytic therapy for pulmonary embolism;Cochrane Database of Systematic Reviews;2021-04-15

2. Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial;BMC Pulmonary Medicine;2021-02-28

3. THERAPEUTIC EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN COMBINED WITH WARFARIN SEQUENTIAL ANTICOAGULANT TREATMENT ON ACUTE PULMONARY EMBOLISM;ACTA MEDICA MEDITERR;2019

5. Thrombolytic therapy for pulmonary embolism;Cochrane Database of Systematic Reviews;2018-12-18